The largest database of trusted experimental protocols

Apc cy7 f4 80 antibody

Manufactured by BioLegend
Sourced in United States

The APC-Cy7-F4/80 antibody is a fluorescently labeled antibody that binds to the F4/80 antigen, which is expressed on the surface of macrophages and related cells. This antibody can be used for the identification and analysis of macrophage populations in flow cytometry applications.

Automatically generated - may contain errors

2 protocols using apc cy7 f4 80 antibody

1

Characterizing Alveolar Macrophages by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung mononuclear cells (MNCs) were re-suspended in FACS buffer (cat. no. 00-4222; eBioscience, Inc.) (2×106 cells/ml) and stained with a PE-cluster of differentiation (CD) 11c antibody (cat. no. 561044; eBioscience; Thermo Fisher Scientific, Inc.) and APC-Cy7-F4/80 antibody (cat. no. 123117; BioLegend, Inc.) to characterize the alveolar macrophages (AMs) as CD11c and F4/80 double-positive cells. The antibodies fluorescein isothiocyanate (FITC)-major histocompatibility complex (MHC) II (cat. no. 556643), FITC-CD80 (cat. no. 553768), FITC-CD40 (cat. no. 561845), FITC-CD206 (cat. no. 551135), FITC-IL-10 (cat. no. 554466; eBioscience Inc.) and APC-CD86 (cat. no. 102513; BioLegend, Inc.) were used to perform the second cell surface staining. All cells were analyzed by flow cytometry (FACSAria III; BD Bioscences). The results were analyzed using FlowJo (version 10.0.7r2; FlowJo LLC)
+ Open protocol
+ Expand
2

Characterization of Lung and Bone Marrow-Derived Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the phenotype of DCs in lung tissue and BMDCs, prepared lung mononuclear cells (MNCs) and BMDCs were suspended in a FACS buffer at 2 × 106 cells/ml. DCs express the marker CD11c but not the marker F4/80 on the cell surface; therefore, DCs were gated as CD11c+/F4/80 cells using the PE-CD11c antibody (eBioscience, San Diego, CA, USA) and the APC-Cy7-F4/80 antibody (BioLegend Inc., San Diego, CA, USA). Next, the cells were stained with the following antibodies: FITC-MHCII, FITC-CD80, FITC-CD40, FITC-B220, FITCICAM-1 (eBioscience, San Diego, CA, USA), APC-CD86, APC-CCR7, APC-CD11b (Biolegend Inc., San Diego, CA, USA). All cells were analyzed by flow cytometry (FACSAria™ III, BD Biosciences, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!